NVDAMillionaire Posted - 12/31/24

$COO The Cooper Companies, Inc. (NYSE:COO): A Healthcare Powerhouse Navigating the Complex Landscape https://beyondspx.com/article/the-cooper-companies-inc-nyse-coo-a-healthcare-powerhouse-navigating-the-complex-landscape

Estimize Posted - 12/30/24

Wall St is expecting 0.91 EPS for $COO Q1 [Reporting 02/27 AMC] http://www.estimize.com/intro/coo?chart=historical&metric_name=eps&utm_cont

xMonti Posted - 12/27/24

$STAA $JNJ $PLTR $COO $BHC https:// Deep Dive: Myopia rising in Hong Kong www.scmp.com/yp/discover/news/hong-kong/article/3234613/deep-dive-myopia-rising-hong-kong-children-due-more-screen-time-changing-habits-during-and-after

xMonti Posted - 12/23/24

$JNJ $ALC $BHC $COO $STAA While advancements in corrective measures such as glasses, surgery, and visual rehabilitation offer hope, the expert warned that these solutions alone are not enough to counter the rising trend of vision problems. https://www.nst.com.my/amp/news/nation/2024/12/1151252/expert-one-10-children-malaysia-suffers-severe-vision-problem

xMonti Posted - 12/23/24

$STAA $JNJ $BHC $ALC $COO Study finds increase in myopia with young people https://www.cbsnews.com/newyork/video/study-finds-increase-in-myopia-with-young-people/

xMonti Posted - 12/23/24

$STAA $JNJ $BHC $ALC $COO Recent reports show that Korea has become the country with the fastest growing myopia population in Asia https://www.koreabiomed.com/news/articleViewAmp.html?idxno=25469

xMonti Posted - 12/23/24

$STAA $JNJ $ALC $COO $BHC A third of the world’s youth is near-sighted. In parts of East Asia, it’s 90% . the most affected countries are Japan, Korea, Russia, Singapore, and China. Demands for Contact lens & ICL will grow significantly in East Asia

CoolE Posted - 12/19/24

$COO I like it in here …few calls for a long term swing

smartkarma Posted - 12/14/24

$COO | The Cooper Companies: Expansion of MyDay Capacity As A Vital Factor Driving Growth! - Major Drivers "Cooper Companies reported a record revenue year for fiscal 2024, achieving $3.9 billion primarily driven by strong performances from its two main..." - Baptista Research (Baptista Research) Read more: https://www.smartkarma.com/insights/the-cooper-companies-expansion-of-myday-capacity-as-a-vital-factor-driving-growth-major-drivers

topstockalerts Posted - 12/06/24

$COO For its fiscal fourth quarter ended Oct. 31, the company reported adjusted earnings of $1.04 per share, beating Wall Street’s call for $1, according to FactSet. Revenue of $1.02 billion was below the consensus estimate for $1.03 billion. That caused the stock to trade lower, argued William Blair analysts led by Margaret Kaczor Andrew, who rate shares at Outperform. “The miss was driven by CooperSurgical (CSI) revenues $5 million below our estimate, offset by another quarter of above-market growth (8% organic) and share gains in CooperVision (CVI),” the team wrote. For fiscal 2025, the company is calling for adjusted earnings between $3.92 and $4.02, while analysts had penciled in $4.07.

d_risk Posted - 12/06/24

$COO - The Cooper Companies Inc. Common Stock - 10K - Updated Risk Factors Cooper Companies' 2024 10-K Risk Factors reflect expanded focus on regulatory, geopolitical, and operational risks, with new concerns over data security, sanctions, tax changes, and internal control weaknesses, alongside intensified competition and compliance challenges. #Risk https://d-risk.ai/COO/10-K/2024-12-06

ChefPhil Posted - 12/06/24

@Olddrache yea I should have played this instead of $coo

ChefPhil Posted - 12/06/24

$COO iv crush 😩

trading_momentum Posted - 4 weeks ago

Other notable ERs this evening $LULU $ULTA $HPE $COO is the only one down (10 pts)

ChefPhil Posted - 4 weeks ago

@Olddrache $coo level 2 looks weird could you take a look for me.

DonCorleone77 Posted - 4 weeks ago

$COO Cooper Companies reports Q4 EPS $1.04, consensus $1 Reports Q4 revenue $1.02B, consensus $1.03B.Commenting on the results, Al White, Cooper's President and CEO said, "Fiscal 2024 was a great year for Cooper having achieved record consolidated revenues, including record CooperVision revenues, record CooperSurgical revenues and record non-GAAP EPS. We look forward to continued success in fiscal 2025 and thank all of our employees for driving these results."Cash provided by operations of $268.1M offset by capital expenditures of $139.9M resulted in free cash flow of $128.2M.

Olddrache Posted - 4 weeks ago

$COO 12/20 expected move 6.79%

ChefPhil Posted - 4 weeks ago

@Olddrache any flow sir on $coo?

ChessGM Posted - 1 month ago

$COO Heads up alert! Only two days until Upcoming earnings on Thursday, 12/5/2024 for $COO Neutral (5.6) The Cooper Companies (COO) is positioned in a dynamic sector, and recent assessments highlight a mixed outlook heading into its fourth-quarter earnings report. The company is projected to benefit from segmental strength, which is expected to drive both top-line and bottom-line performance. Key financial metrics indicate a robust P/E ratio, suggesting that the stock is relatively valued compared to its peers. For instance, COO has maintained a strong EPS growth trajectory, with recent estimates suggesting a year-over-year increase. Revenue forecasts are also positive, buoyed by anticipated growth in both the contact lens and surgical segments, which have historically outperformed industry averages. However, a rise in selling, general, and administrative expenses raises some caution among analysts, indicating potential pressure on margins. Comparatively, COO's 7.5% CAGR over the last five years highlights its ability to generate consistent returns for shareholders, further reinforcing its standing in the market. Looking ahead to the upcoming earnings report scheduled for December 5, 2024, analysts are keenly focused on expectations surrounding key performance indicators. The consensus estimates project that COO will report robust earnings driven primarily by strong segmental sales. Historical performance shows that COO has consistently beaten earnings estimates in previous quarters, making analysts optimistic about the upcoming results. The anticipated release will be closely watched, as it may influence investor sentiment and provide further clarity on the company's operational efficiency and strategic initiatives. The potential impact of recent interest rate cuts by the Federal Reserve may also play a role in shaping COO's financial outlook, as lower rates could enhance consumer spending and positively affect revenue streams. Overall, while there are areas of concern regarding expense management, the overall sentiment remains cautiously optimistic ahead of the earnings announcement. - Funds were net sellers of $COO during the previous reporting quarter. - Here are some of the funds with a sizable holdings (as of Q4 of 2024) for $COO: * Veritas Capital Fund Management LLC $487MM. CGMFundRank: 71%, Fund Website: www.veritascapital.com * Generation Investment Management LLP $458MM. CGMFundRank: 74%, Fund Website: www.generationim.com * Holocene Advisors LP $124MM. CGMFundRank: 87%, Fund Website: www.holoceneadvisors.com * Jennison Associates LLC $89MM. CGMFundRank: 86% * Gladstone Capital Management LLP $84MM. CGMFundRank: 84% - Last 10 days performance: 4% - Last 30 days performance: -1% - Last 90 days performance: -2% Some most recent news articles for $COO: Strong Segmental Sales to Drive Cooper Companies Q4 Earnings? https://finance.yahoo.com/news/strong-segmental-sales-drive-cooper-135800899.html?.tsrc=rss Unveiling The Cooper Companies (COO) Q4 Outlook: Wall Street Estimates for Key Metrics https://finance.yahoo.com/news/unveiling-cooper-companies-coo-q4-182948091.html?.tsrc=rss Meridian Growth Fund Trimmed The Cooper Companies (COO) For Valuation Discipline https://finance.yahoo.com/news/meridian-growth-fund-trimmed-cooper-172208839.html?.tsrc=rss CooperCompanies Announces Release Date for Fourth Quarter and Full Year 2024 https://finance.yahoo.com/news/coopercompanies-announces-release-date-fourth-211500977.html?.tsrc=rss Follow ChessGM on stocktwits.com to get timely earnings alerts. Not a financial advice. Not a trading signal.

Estimize Posted - 11/28/24

Wall St is expecting 1.00 EPS for $COO Q4 [Reporting 12/05 AMC] http://www.estimize.com/intro/coo?chart=historical&metric_name=eps&utm_cont

JackDarwin Posted - 11/27/24

$COO Nice Bullish Engulfing Formed.

Estimize Posted - 11/12/24

Wall St is expecting 1.00 EPS for $COO Q4 [Reporting 12/05 AMC] http://www.estimize.com/intro/coo?chart=historical&metric_name=eps&utm_cont

HerbertLincoln853 Posted - 2 months ago

$COO AITX continually shines with their technological advancements, while KSCP's lack of visible progress is making me reconsider my investment portfolio.

Trader_Ty Posted - 10/28/24

$COO (195min) Flagging off the earnings move last month with volume coming in over the last few sessions

Doozio Posted - 10/27/24

$COO out of da tightness wen da FUTUre of 🧠⏰ is NOW during 🧠⏰♾️

jjmstocks1 Posted - 10/27/24

$COO +15% YTD .. global med device company finishes inside on fridays session .. but look at the volume on thurs & fri session .. ~2.5x above the avg volume .. i took a look and thats the most activity this names had all year ..

WeeklyTrader Posted - 10/12/24

Bearish sentiment rising! Grab a PUT on $COO at strike 105.0p! RSI: 51.92% 50-day MA: $102.48 200-day MA: $96.28

WeeklyTrader Posted - 10/10/24

Prepare for a bumpy ride with $COO!

insiderbuyingselling Posted - 09/20/24

$COO new insider selling: 114992 shares. http://insiderbuyingselling.com/?t=COO

HammerstoneMarkets Posted - 09/17/24

$BLCO +3.71% after y'day's +14% gain following an article on Saturday in the @FT stating that Bausch + Lomb is exploring a sale to separate itself from parent Bausch Health ( $BHC). This morning: -A Jefferies note said a sale would be a big positive for $BHC's (Buy, $9 PT) equity & debt shareholders. On Monday: -Wells Fargo said a sale "makes sense to us given the steep valuation discount between $BLCO (OW, $23 PT) and its closest eye care peers." -JPMorgan disagreed, saying the valuation discount (vs $COO & $ALC) is warranted b/c 70% of $BLCO's (Neutral) earnings emanate from their drug units & not eye care units. - $BHC -shares are +12.6% over the past 2 days